Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025

Bacteriophage Therapy as a Next Generation Solution for Treating Drug Resistant Bacterial Infections

View Full Paper
Ask AI
Bookmark
Share

Authors

PSPrashant SinghRSRanjan Singh

Discussion

Loading...

Member takes

Overview

Observational analysis reveals bacteriophage therapy's promise against MDR and XDR infections, suggesting it could complement traditional antibiotics.

Key Points

  • Bacteriophage therapy shows promise in treating life-threatening infections caused by drug-resistant bacteria.
  • Clinical studies indicate that phages effectively target and lyse bacteria like Pseudomonas aeruginosa, enhancing treatment options.
  • Advancements in phage engineering have improved the safety and efficacy of tailored phage cocktails against biofilm-associated infections.
  • Regulatory challenges and bacterial resistance to phages highlight the need for further research to integrate bacteriophage therapy effectively.

Cite This Study

Singh et al. (2023) studied this question.

synapsesocial.com/papers/68c1e24854b1d3bfb60ff1achttps://doi.org/10.51470/ma.2023.5.2.21
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The application value of bacteriophage in patients with severe drug-resistant bacterial infections2024 · 3 citations
  2. 2Phage therapy against multiresistant bacteria2024 · 3 citations
  3. 3Bacteriophage therapy: an alternative to antibiotics in the age of multi-drug resistance2024 · 1 citations
  4. 4BACTERIOPHAGE THERAPY: A PROMISING ALTERNATIVE TO ANTIBIOTICS IN THE ERA OF MULTIDRUG RESISTANCE2026
  5. 5Jumping Over Hurdles: Challenges and Solutions in Phage Therapy2026